Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 11874847.
- Also identified by PMC identifier 1754065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A working report from the OMERACT Health Economics Group. The group is working towards creating common standards for economic evaluation in rheumatology and also towards improving the scientific underpinning of economic evaluation, particularly pertaining to the rheumatic diseases. Preliminary recommendations for "reference cases" in osteoporosis, rheumatoid arthritis, and osteoarthritis are proposed.
Medical subject headings
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Practice Guidelines as Topic
- Rheumatic Diseases